Angela Chan
Image of Angela Chan

Angela Chan

Associate

Angela is experienced in advising private equity funds, other financial sponsors and corporates on a range of transactions, including buyouts, mergers, exits, joint ventures and preferred equity investments.
Angela spent six months on secondment at Charterhouse Capital Partners in 2021 and six months at A&O Shearman’s New York office in 2023.

Expertise

Experience

Representative matters

  • Strikwerda Investments on its €800m strategic preferred equity investment from Ares Management and Carlyle.
  • Cinven’s Strategic Financials Fund on its acquisition of a 50% interest in Policy Expert.
  • Stellex Capital on its acquisition of Fox Brothers.
  • Ardian on the sale of Audiotonix to PAI Partners.
  • Haleon plc on the sale of ChapStick to Suave Brands.
  • Exponent Private Equity on its acquisition of Natara from International Flavors & Fragrances Inc.
  • OMERS Private Equity on its acquisition of Network Plus.
  • Exponent Private Equity on the sale of the BBI Group to Novo Holdings.
  • Exponent Private Equity on the sale of BBI Healthcare to Venture Life Group plc.

Qualifications

Admissions

– Admitted as a Solicitor (England and Wales), 2022

– BA, Law, University of Cambridge, 2019

Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.